Key Metrics of Zoetis
Revenue$8.5B▲ 5.7% YoYFY 2023
Operating income—
Net profit$2.3B▲ 10.9% YoY
Shareholders' equity$5.0B
Market cap$33.9BZTS · $82.00
Competitors10identified
About Zoetis
Sectors
Company details
- Website
- zoetis.com
- Founded
- 2013
- Listed
- NYSE: ZTS (since 2013)
Operational Areas of Zoetis
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameZoetis Inc.
TickerZTS
ExchangeNYSE
CountryUnited States
SEC CIK0001555280
Listed since2013
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.zoetis.com
US market & SEC filings
ZTS · NYSE · SEC CIK 0001555280
Last price · 23 Oct 2026
$82.00
+2.99%
Market cap$33.9B
P/E16.2On FY 2023 diluted EPS
Volume4,828,396
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 2013
ZTS share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeFlorham Park
GSTIN—
Email—
Websitehttp://www.zoetis.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Zoetis
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.